Flow cytometry market research report is an extensive investigation of how the analytical instruments industry is changing due to the Flow cytometry market. There are a few deliberate data in the report, similar to the estimation of CAGR values in the estimated year of 2019-2025, and the market definition, arrangements, applications, and market patterns imply and how to utilize them to accomplish a more prominent edge on the key players and brands. The report all the while reveals insight into the market drivers and limitations with the assistance of SWOT analysis. This report is a magnificent guide for noteworthy thoughts, upgraded basic leadership, and better business methodologies.
The market studies, cognizance, and analysis executed in Flow cytometry market research report keeps commercial center unmistakably into the center which accomplishes a business objective. It comprehensively assesses general economic situations, the development prospects in the market, potential limitations, noteworthy industry patterns, market estimate, market share, deals volume and future patterns. This report likewise contains the organization profiles of the top players and brands and their ongoing advancements, item dispatches, joint endeavors, mergers and allegations by the top brands and players.
Download FREE PDF Sample Copy of Report https://databridgemarketresearch.com/request-a-sample/?dbmr=europe-flow-cytometry-market
Competitive Analysis: Europe Flow Cytometry Market
Some of the major players operating in this market are Bio-Rad Laboratories, Inc., Miltenyi Biotec Sysmex Partec GmbH, BIOMÉRIEUX, Mechatronics,, Apogee Flow Systems Ltd., Stratedigm, Inc., Sony Biotechnology Inc., BD., Thermo Fisher Scientific Inc., Merck KGaA, ACEA BIO, Agilent Technologies , Luminex Corporation. , Enzo Life Sciences, Inc., Beckman Coulter, Inc., Takara Bio Inc. among others.
Europe flow cytometry market is expected to reach at a CAGR of 8.2% in the forecast period of 2018 to 2025.
TABLE OF CONTENTS
1.1. Market Definitions
1.2. Research Methodology
1.3. Market Segmentation
3.4. Premium Market Trends
4.1. Value Chain Analysis
4.2. Technology Roadmap
Get detailed toc @ https://databridgemarketresearch.com/toc/?dbmr=europe-flow-cytometry-market
Segmentation: Europe Flow Cytometry Market
Europe flow cytometry market is segmented into four segments which are technology, products, and end user and application.
On the basis of technology, the market is segmented into cell-based flow cytometry and bead-based flow cytometry. Cell-based flow cytometry is dominating the market and bead-based flow cytometry segment is growing at the highest CAGR of in the forecast period of 2018 to 2025.
In April 2018, Merck KGaA (Germany) launched its new Cell Stream benchtop flow cytometry system which is a compressed, customizable flow cytometer that use a camera for detection. It is a unique optics system and design provides researchers with unparalleled sensitivity and flexibility when analyzing cells and submicron particles. With this launch of the product company has expanded their product line in flow cytometers.
On the basis of products, the market is segmented into categorized into reagents and consumables, flow cytometry instruments, accessories and services. The segment reagents and consumables are further sub segmented into antibodies, dyes, beads and others. The segment flow cytometry instruments are further sub segmented into cell analyzers and cell sorters. The segment services are further sub segmented into filters, laser devices, detectors and others. Flow cytometry instruments segment is growing at the highest CAGR of in the forecast period of 2018 to 2025.
In February 2014, Bio-Rad Laboratories, Inc. (U.S.), announced the launch of its ReadiLink antibody labeling kits, one of the market’s simplest antibody conjugation solution for labeling microscale amounts (50–100 µg) of antibody. These kits are ideal for researchers interested in labelling their own antibodies for flow cytometry and cell sorting applications.
On the basis of application, the market is segmented into research applications, clinical application and industrial applications. Research application market is further sub segmented into pharmaceutical and biotechnology, immunology, apoptosis, cell sorting/ screening, cell cycle analysis, cell transfection/viability, cell counting, other research applications. Pharmaceutical and biotechnology are further segmented into drug discovery, stem cell research, in vitro toxicity testing. The clinical applications are further sub segmented into cancer, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications. Clinical application segment is growing at the highest CAGR of in the forecast period of 2018 to 2025.
In September 2017, Beckman Coulter, Inc. (U.S.), has launch their first flow cytometry CytoFLEX LX for the cancer researchers which has the visible spectrum in a standard configuration. From this launch of the product they have expanded their business in flow cytometry.
On the basis of end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals, clinical testing laboratories, blood bank and others. Academic & research institutes segment is growing at the highest CAGR of in the forecast period of 2018 to 2025.
In July 2017, Beckman Coulter, Inc. (U.S.), has received U.S. FDA approval for its clinical flow cytometry product, the Navios EX flow cytometer, to be used in the clinical laboratory in the US. The Navios EX delivers accurate, high complexity immunophenotyping using Tetra reagents. The compact, 10-color Navios EX incorporates the advanced optics and laser technology of the company’s award-winning CytoFLEX research flow cytometer. From this clearance Beckman Coulter, Inc. has enhanced their product portfolio in flow cytometry.
In August 2018, Sysmex Partec GmbH (Germany) announced the notice about clearance of WHO prequalification. This testing system helps diagnose and monitor the immune status of people infected with HIV by checking CD4 in human blood samples. The CyFlow Counter System, which has received WHO prequalification, comprises a compact, robust desktop flow cytometer (CyFlow Counter) and a group of related reagents (CD4 easy count kit/CD4% easy count kit).
In September2017, Miltenyi Biotec GmbH (Germany) launched a fully automated high-throughput flow cytometry MACSQuant X which handles 384-well plates in less than 60 minutes giving users fast, reliable, and reproducible results. Launching this product expanded the flow cytometry product line of company.
In November 2016, Sysmex Partec GmbH (Germany) launched the RF-500 flow cytometer, its new product for the research and industrial domains. The instrument will be on exhibit with the Molecular Biology Society of Japan and the Japanese Society for Immunology. The states of individual cells and the interactions between cells have a significant impact on phenomena (such as disease states) that occur within the body.
In September 2016, Miltenyi Biotec GmbH (Germany) offered flow cytometry antibodies in a concentrated format of 2 μL of antibody per test. This is because of increasing demand for smaller pipetting volumes for multicolour panels with many antibodies.
Inquire Regarding This Report https://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-flow-cytometry-market